The report provides a detailed analysis essential for establishing a rizatriptan benzoate production plant. It encompasses all critical aspects necessary for rizatriptan benzoate production, including the cost of rizatriptan benzoate production, rizatriptan benzoate plant cost, rizatriptan benzoate production costs, and the overall rizatriptan benzoate production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a rizatriptan benzoate production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Rizatriptan Benzoate is a pharmaceutical compound mainly used for the treatment of migraine headaches. It is primarily used as a medication in the treatment of migraine headaches by helping relieve symptoms such as severe head pain, nausea, and sensitivity to light or sound. It belongs to a group of medicines called triptans, which help relieve migraine symptoms by narrowing blood vessels around the brain and blocking pain signals. It is commonly formulated into tablets and orally disintegrating tablets for quick and effective relief. It works by inducing vasoconstriction of cranial blood vessels and inhibiting the release of neuropeptides, thereby providing relief from migraine headaches. Moreover, it is widely used in hospitals, clinics, and prescription-based therapies for patients suffering from recurring migraines. In addition, it is also involved in pharmaceutical research to explore its potential in improving migraine management and developing advanced headache treatments.
The market for rizatriptan benzoate is driven by its application as a medication in the treatment of acute episodes of migraine, which strengthens its demand in the pharmaceutical industry. Its application as a drug in the treatment of migraine headaches with or without aura in adults also supports its demand in the medical and pharmaceutical industries. Its demand as an important pharmaceutical compound in migraine care and modern neurological medicine significantly boosts its market growth.
Its utilisation for its fast-acting relief of migraine symptoms such as headache, nausea, and sensitivity to light or sound further drives its demand in the pharmaceutical and neurology sectors. Industrial rizatriptan benzoate procurement is influenced by multiple factors, including the cost and steady availability of active pharmaceutical ingredients, regulatory approvals across different regions, and production efficiency. Moreover, advancements in drug formulation, supplier dependability, global distribution networks, and adherence to international quality standards play a major role in shaping its procurement practices.
Raw Material for Rizatriptan Benzoate Production
According to the rizatriptan benzoate production plant project report, the major raw materials for rizatriptan benzoate production include 4-chlorobutanal, sodium metabisulfite, 1-(4-hydrazinylphenyl)methyl-1,2,4-triazole hydrochloride, dimethylamine, and benzoic acid.
Production Process of Rizatriptan Benzoate
The extensive rizatriptan benzoate production cost report consists of the following industrial production process:
- Production via Chemical Synthesis: The production process of rizatriptan benzoate begins with the addition reaction between 4-chlorobutanal and sodium metabisulfite to form sodium 4-chlorobutane-1,1-disulfonate. Then, this intermediate reacts with 1-(4-hydrazinylphenyl)methyl-1,2,4-triazole hydrochloride in an alcohol-water mix with a catalyst, followed by alkali neutralisation, solvent extraction, and concentration to give 3-(2-chloroethyl)-5-(1H-1,2,4-triazol-1-ylmethyl)-1H-indole. Then, this compound reacts with dimethylamine in the presence of a phase-transfer catalyst to produce rizatriptan. Finally, the resulting rizatriptan is combined with benzoic acid in a solvent to form rizatriptan benzoate salt, which is purified using ethanol for the finished product.
Rizatriptan Benzoate is the benzoate salt form of rizatriptan, and it acts as a selective serotonin 5-HT1B/1D receptor agonist. It appears as a white to off-white crystalline solid or powder. The molecular formula of the compound is C22H25N5O2, and its molar mass is 391.47 g/mol. Its density is approximately 1.21 g/cm³, and its melting point ranges from 178 degree Celsius to 180 degree Celsius. The boiling point of the compound is approximately 504.8 degree Celsius, and its flash point is around 259.1 degree Celsius. The compound is soluble in water at about 42 mg per mL at 25 degree Celsius. The compound is marketed under the brand name Maxalt. Common side effects associated with the compound include dizziness, drowsiness, fatigue, dry mouth, and nausea. It is contraindicated in patients with cardiovascular disease, and caution is advised when combining with monoamine oxidase inhibitors or other serotonergic medications due to the risk of serotonin syndrome.